My Account Log in

2 options

FDA user fee reauthorization : ensuring safe and effective medical devices : hybrid hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventeenth Congress, second session, March 30, 2022.

Online

Available online

View online

U.S. Government Documents Available online

View online
Format:
Book
Government document
Author/Creator:
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
Language:
English
Subjects (All):
United States. Food and Drug Administration.
United States.
User charges--United States.
User charges.
Drug approval--United States.
Drug approval.
Medical supplies--Certification--United States.
Medical supplies.
Genre:
Legislative hearings.
Physical Description:
1 online resource (v, 123 pages) : color illistrations
Other Title:
Ensuring safe and effective medical devices
Food and Drug Administration user fee reauthorization
Place of Publication:
Washington : U.S. Government Publishing Office, 2026.
Participant:
Hearing witnesses: Jeff Shuren, M.D., Director, Center for Devices and Radiological Health, Food and Drug Administration; Richard J. Kovacs, M.D., Q.E. and Sally Russell Professor of Medicine, Indiana University School of Medicine, Chief Medical Officer, American College of Cardiology; Mark Leahey, President and CEO, Medical Device Manufacturers Association; Janet Trunzo, Senior Executive Vice President, Technology And Regulatory Affairs, Advanced Medical Technology Association; Diane Wurzburger, Executive of Regulatory Affairs, GE Healthcare.
Notes:
This is a publication issued by the United States federal government or produced with federal funds.
Associated bill citation(s): H.R. 7084; H.R. 7192.
"Serial no. 117-77."
Includes bibliographical references.
Date of hearing: 2022-03-30.
Description based on online resource, PDF version; title from title page (GovInfo, viewed Mar. 12, 2026).
In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
Other Format:
Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. FDA user fee reauthorization
OCLC:
1579072155
Publisher Number:
60-330 (GPO jacket number)

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Library Catalog Using Articles+ Library Account